nirogacestat
oral gamma secretase inhibitor Ph. III for DT/AF + Ph. II for OvGCTs single-digit nanomolar potency for Aβ reduction in vitro Press release, February 27, 2023 / NEJM, March 9, 2023 Pfizer / SpringWorks Therapeutics, Inc.
Molecules of the Month - March 2023